Contrary to data indicating an overall incidence of 2% [11], this could be attributed to the fact that patients with an occult melanoma inherently present at a higher tumor stage, thereby warranting an indication for BRAF mutation analysis. This evidence concerns the gene BRAF and neoplasm.